SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-20-005304
Filing Date
2020-03-16
Accepted
2020-03-16 15:57:58
Documents
99
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K acrx20191231_10k.htm 10-K 2211298
2 EXHIBIT 4.1 ex_177093.htm EX-4.1 28073
3 EXHIBIT 10.16 ex_177092.htm EX-10.16 9590
4 EXHIBIT 10.17 ex_177094.htm EX-10.17 9392
5 EXHIBIT 21.2 ex_176476.htm EX-21.2 1540
6 EXHIBIT 23.1 ex_176477.htm EX-23.1 6237
7 EXHIBIT 31.1 ex_176478.htm EX-31.1 9732
8 EXHIBIT 31.2 ex_176479.htm EX-31.2 9686
9 EXHIBIT 32.1 ex_176480.htm EX-32.1 6928
16 acrx20191231_10kimg001.gif GRAPHIC 13313
  Complete submission text file 0001437749-20-005304.txt   9497710

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT acrx-20191231.xml EX-101.INS 1946507
11 XBRL TAXONOMY EXTENSION SCHEMA acrx-20191231.xsd EX-101.SCH 98870
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20191231_cal.xml EX-101.CAL 58485
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20191231_def.xml EX-101.DEF 569524
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20191231_lab.xml EX-101.LAB 546524
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20191231_pre.xml EX-101.PRE 618055
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35068 | Film No.: 20717001
SIC: 2834 Pharmaceutical Preparations